Research ArticleMetabolism

SerpinB13 antibodies promote β cell development and resistance to type 1 diabetes

See allHide authors and affiliations

Science Translational Medicine  07 Apr 2021:
Vol. 13, Issue 588, eabf1587
DOI: 10.1126/scitranslmed.abf1587

Article Information

vol. 13 no. 588

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication October 7, 2020
  • Accepted for publication March 15, 2021
  • .

Author Information

  1. Yury Kryvalap1,
  2. Matthew L. Jiang2,
  3. Nadzeya Kryvalap2,
  4. Cole Hendrickson1 and
  5. Jan Czyzyk1,*
  1. 1Department of Laboratory Medicine and Pathology, University of Minnesota, 420 Washington Ave. SE, Minneapolis, MN 55455, USA.
  2. 2Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY 14642, USA.
  1. *Corresponding author. Email: jczyzyk{at}umn.edu

Altmetric

Article usage

Article usage: April 2021 to April 2021

AbstractFullPdf
Apr 20214270501192

Stay Connected to Science Translational Medicine